Cromwell O - Search Results

1

Strategies for recombinant allergen vaccines and fruitful results from first clinical studies.

Cromwell O, Fiebig H, Suck R, Kahlert H, Nandy A, Kettner J, Narkus A. Cromwell O, et al. Immunol Allergy Clin North Am. 2006 May;26(2):261-81, vii. doi: 10.1016/j.iac.2006.02.001. Immunol Allergy Clin North Am. 2006. PMID: 16701144 Review.

2

Purification strategy for recombinant Phl p 6 is applicable to the natural allergen and yields biochemically and immunologically comparable preparations.

Suck R, Weber B, Schäffer B, Diedrich E, Kamionka T, Fiebig H, Cromwell O. Suck R, et al. Among authors: cromwell o. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Apr 25;787(2):357-68. doi: 10.1016/s1570-0232(02)00966-2. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12650758

3

Analytical and preparative native polyacrylamide gel electrophoresis: Investigation of the recombinant and natural major grass pollen allergen Phl p 2.

Suck R, Petersen A, Weber B, Becker WM, Fiebig H, Cromwell O. Suck R, et al. Among authors: cromwell o. Electrophoresis. 2004 Jan;25(1):14-9. doi: 10.1002/elps.200305697. Electrophoresis. 2004. PMID: 14730563

4

Transition of recombinant allergens from bench to clinical application.

Cromwell O, Suck R, Kahlert H, Nandy A, Weber B, Fiebig H. Cromwell O, et al. Methods. 2004 Mar;32(3):300-12. doi: 10.1016/j.ymeth.2003.08.009. Methods. 2004. PMID: 14962765 Review.

5

Mechanisms of immunotherapy with allergoids: lessons for the development of recombinant allergens with reduced IgE-binding activity.

Cromwell O, Kahlert H, Schramm G, Suck R, Nandy A, Weber B, Fiebig H. Cromwell O, et al. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003;(94):156-61; discussion 161-2. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003. PMID: 15119034 No abstract available.

6

Allergen-specific immunotherapy with recombinant grass pollen allergens.

Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Jutel M, et al. Among authors: cromwell o. J Allergy Clin Immunol. 2005 Sep;116(3):608-13. doi: 10.1016/j.jaci.2005.06.004. J Allergy Clin Immunol. 2005. PMID: 16159631 Clinical Trial.

7

Primary structure, recombinant expression, and molecular characterization of Phl p 4, a major allergen of timothy grass (Phleum pratense).

Nandy A, Petersen A, Wald M, Suck R, Kahlert H, Weber B, Becker WM, Cromwell O, Fiebig H. Nandy A, et al. Among authors: cromwell o. Biochem Biophys Res Commun. 2005 Nov 18;337(2):563-70. doi: 10.1016/j.bbrc.2005.09.087. Epub 2005 Sep 22. Biochem Biophys Res Commun. 2005. PMID: 16198308

8

Clinical evaluation of recombinant allergens.

Cromwell O, Narkus A. Cromwell O, et al. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2006;(95):195-200; discussion 200-3. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2006. PMID: 17393740 No abstract available.

9

Patient-tailored recombinant allergen products--mission impossible?

Cromwell O, Matricardi PM, Fiebig H. Cromwell O, et al. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009;96:210-7; discussion 217-8. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009. PMID: 20799463 No abstract available.

10

Recombinant allergens for specific immunotherapy.

Cromwell O, Häfner D, Nandy A. Cromwell O, et al. J Allergy Clin Immunol. 2011 Apr;127(4):865-72. doi: 10.1016/j.jaci.2011.01.047. Epub 2011 Mar 5. J Allergy Clin Immunol. 2011. PMID: 21377719 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters